[go: up one dir, main page]

NO893879D0 - PROCEDURE FOR THE PREPARATION OF PTERID-CONTAINING MEDICINAL PRODUCTS. - Google Patents

PROCEDURE FOR THE PREPARATION OF PTERID-CONTAINING MEDICINAL PRODUCTS.

Info

Publication number
NO893879D0
NO893879D0 NO893879A NO893879A NO893879D0 NO 893879 D0 NO893879 D0 NO 893879D0 NO 893879 A NO893879 A NO 893879A NO 893879 A NO893879 A NO 893879A NO 893879 D0 NO893879 D0 NO 893879D0
Authority
NO
Norway
Prior art keywords
group
pteridines
preparation
substituted
carbon atom
Prior art date
Application number
NO893879A
Other languages
Norwegian (no)
Other versions
NO175979C (en
NO893879L (en
NO175979B (en
Inventor
Armin Heckel
Joerg Lebsanft
Uwe Bamberger
Avner Ramu
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO893879D0 publication Critical patent/NO893879D0/en
Publication of NO893879L publication Critical patent/NO893879L/en
Publication of NO175979B publication Critical patent/NO175979B/en
Publication of NO175979C publication Critical patent/NO175979C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to medicaments containing a pteridine of the formula <IMAGE> in which n is the number 0 or 1, R2 and R7 are each a pyrrolidino, piperidino or morpholino group which is optionally substituted by one or two methyl groups, R3 is a straight-chain or branched alkyl group in which one or two carbon atoms, excepting the carbon atom adjacent to the nitrogen atom, can be substituted by a hydroxyl group, R<4> is an alkyl or phenylalkyl group, in which one carbon atom, excepting the carbon atom adjacent to the nitrogen atom, can be substituted by a hydroxyl group, and R5 is a hydrogen atom or a methyl group, or the acid addition salts thereof and at least one chemotherapeutic from the natural product series, and to the use of the above pteridines for sensitisation of tumours during chemotherapy with the abovementioned chemotherapeutics, and to pteridines, process for the preparation thereof and medicaments containing these pteridines.
NO893879A 1988-10-01 1989-09-29 Analogous Process for Preparation of Therapeutically Active Pteridines NO175979C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3833393A DE3833393A1 (en) 1988-10-01 1988-10-01 USE OF PTERIDINES TO PREVENT PRIMARY AND SECONDARY RESISTANCE IN CHEMOTHERAPY AND MEDICINES CONTAINING THESE COMPOUNDS

Publications (4)

Publication Number Publication Date
NO893879D0 true NO893879D0 (en) 1989-09-29
NO893879L NO893879L (en) 1990-04-02
NO175979B NO175979B (en) 1994-10-03
NO175979C NO175979C (en) 1995-01-11

Family

ID=6364156

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893879A NO175979C (en) 1988-10-01 1989-09-29 Analogous Process for Preparation of Therapeutically Active Pteridines

Country Status (19)

Country Link
EP (1) EP0362645B1 (en)
JP (1) JPH02256676A (en)
KR (1) KR910006289A (en)
AT (1) ATE106728T1 (en)
AU (1) AU620645B2 (en)
DD (1) DD299062A5 (en)
DE (2) DE3833393A1 (en)
DK (1) DK480489A (en)
ES (1) ES2056174T3 (en)
FI (1) FI92699C (en)
HU (1) HU205761B (en)
IL (1) IL91814A (en)
MX (1) MX9203034A (en)
NO (1) NO175979C (en)
NZ (1) NZ230833A (en)
PT (1) PT91836B (en)
SU (1) SU1720491A3 (en)
UA (1) UA8028A1 (en)
ZA (1) ZA897414B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
WO2000039129A1 (en) * 1998-12-28 2000-07-06 K.U. Leuven Research & Development Immunosuppressive effects of pteridine derivatives
DE10202468A1 (en) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridine derivatives, process for their preparation and their use
PT1663244E (en) * 2003-09-12 2007-11-15 4 Aza Ip Nv Pteridine derivatives for the treatment of tnf-alpha-related diseases.
AU2004283479A1 (en) * 2003-10-17 2005-05-06 4 Aza Bioscience Nv Heterocycle-substituted pteridine derivatives and their use in therapy
RU2447074C2 (en) * 2005-05-12 2012-04-10 Тиботек Фармасьютикалз Лтд. Pteridines effective as hcv inhibitors and methods for producing pteridines
US9259426B2 (en) 2006-07-20 2016-02-16 Gilead Sciences, Inc. 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
WO2008009079A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
EP3722297A1 (en) 2015-03-04 2020-10-14 Gilead Sciences, Inc. Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
KR20160003575A (en) 2015-11-09 2016-01-11 정민시 Power transmitting apparatus for generator
US10640499B2 (en) 2016-09-02 2020-05-05 Gilead Sciences, Inc. Toll like receptor modulator compounds
ES2906581T3 (en) 2016-09-02 2022-04-19 Gilead Sciences Inc Toll-like receptor modulator compounds
TWI751516B (en) 2019-04-17 2022-01-01 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TWI751517B (en) 2019-04-17 2022-01-01 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TWI879779B (en) 2019-06-28 2025-04-11 美商基利科學股份有限公司 Processes for preparing toll-like receptor modulator compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574206A (en) * 1965-04-15 1971-04-06 Boehringer Sohn Ingelheim 2,7-dimorpholino-4-amino-6-phenyl-pteridines
NL129630C (en) * 1966-10-14
DE1617336C2 (en) * 1966-11-25 1982-07-01 C.H. Boehringer Sohn, 6507 Ingelheim Medicines for angina pectoris
DE1795515A1 (en) * 1967-08-18 1972-03-30 Thomae Gmbh Dr K Process for the production of new pteridines
DE1795516A1 (en) * 1967-12-15 1972-01-27 Thomae Gmbh Dr K 4-AEthanolisopropanolamino-2- (2'-methylmorpholino) -7-morpholino-6-phenyl-pteridine
DE1921308A1 (en) * 1969-04-25 1971-01-07 Boehringer Sohn Ingelheim Pharmaceutical prepns. containing one or more of cpds. of general formula (I):- ArOCH2 - CHOH - CH2 - NHR (I) Ar= opt. mono-or polysubstd. iso-, hom
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors

Also Published As

Publication number Publication date
NO175979C (en) 1995-01-11
DK480489D0 (en) 1989-09-29
SU1720491A3 (en) 1992-03-15
AU4174989A (en) 1990-04-05
NO893879L (en) 1990-04-02
FI894615A0 (en) 1989-09-29
DE3833393A1 (en) 1990-04-05
DK480489A (en) 1990-04-02
MX9203034A (en) 1992-07-01
EP0362645B1 (en) 1994-06-08
ZA897414B (en) 1991-06-26
IL91814A0 (en) 1990-06-10
FI92699B (en) 1994-09-15
DD299062A5 (en) 1992-03-26
AU620645B2 (en) 1992-02-20
KR910006289A (en) 1991-04-29
EP0362645A2 (en) 1990-04-11
FI894615A7 (en) 1990-04-02
ATE106728T1 (en) 1994-06-15
PT91836A (en) 1990-04-30
PT91836B (en) 1995-07-18
IL91814A (en) 1994-02-27
EP0362645A3 (en) 1992-03-25
HUT52504A (en) 1990-07-28
DE58907824D1 (en) 1994-07-14
NZ230833A (en) 1991-05-28
NO175979B (en) 1994-10-03
JPH02256676A (en) 1990-10-17
HU205761B (en) 1992-06-29
UA8028A1 (en) 1995-12-26
FI92699C (en) 1994-12-27
ES2056174T3 (en) 1994-10-01

Similar Documents

Publication Publication Date Title
NO893879L (en) PROCEDURE FOR THE PREPARATION OF PTERID-CONTAINING MEDICINAL PRODUCTS.
ATE156823T1 (en) THERAPEUTIC HETEROCYCLIC COMPOUNDS
ES8307743A1 (en) 3-Hydroxypyrrolidin-2-one derivatives, process and intermediates for their preparation and pharmaceutical preparations containing them.
HUT41713A (en) Process for production of //arol-cyclobutyl/ alkyl/-amins and medical preparatives containing thereof
ES390924A1 (en) Esters of substituted nicotine acids
GB1191971A (en) 2-Amino-6,7-Distributed-4H-1,3-Benzothiazine-4-Ones as Bronchodilators
CA1246583A (en) 4-ISOXAZOLYL)-THIAZOLE-2-OXAMIC ACIDS AND THEIR DERIVATIVES
ES8308559A1 (en) Novel quinazoline compound*its manufacture and cardiovascular regulating medicine made from it
ES390064A1 (en) Dibenzo(a-d)cycloheptadi(or tri)ene-5:2&#39;-dioxalanes(i,3&#39;)
EP0233291A4 (en) 2-arylbenzothiazine derivatives.
GB1198283A (en) Novel Sydnonimine Derivatives, the preparation thereof and Compositions containing the same
GB1405767A (en) Method formulation and pharmaceutical composition for reducing plasma lipid levels
ES345994A1 (en) 2-(di - (beta-hydroxy-lower alkyl)amino)-4,7-di - (heterocyclic amino) - 6 - phenyl-pteridines
GB1320548A (en) Nitrofurylaminoalkoxy-pyrimidines
ES8200347A1 (en) Pyridine derivatives, process for their preparation and medicaments containing them.
ES345991A1 (en) PROCEDURE FOR OBTAINING NEW PTERIDINES.
DE3564106D1 (en) 4-phenylaminopyridine derivatives, process of the preparation thereof and pharmaceutical compositions containing them
HU9302260D0 (en) Tetrahydro-naphtaline derivatives and methods for producing these compounds and for preparing pharmaceutical preparatives containing them
GB1085922A (en) Improvements in and relating to therapeutic compositions containing 2-amino-oxazolin-4-one derivatives, novel derivatives of this type and process for preparing same
GB1341170A (en) Alkyl sulphonic acid esters of 1,3,2-oxazaphospha-cyclic compounds
ES485333A1 (en) 5,6,7,8-Tetrahydro-4(3H)- quinazolinone derivatives useful as spasmolytics
ES304710A1 (en) Procedure for the preparation of 1,3,5-triacines (Machine-translation by Google Translate, not legally binding)
FR2670492B1 (en) NEW AMINOALKYLCETONE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATIONS.
ATE28644T1 (en) GAMMA BUTYROLACTONE DERIVATIVES WITH CARIOMUSCULANT AND ANTIARHYTHMIC EFFECTS, PROCESS FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM.